Evaluating the efficacy of Hyperbaric oxygen therapy in the management of Diabetic foot ulcer using Transcutaneous oxygen tension (TcPO2) measurement.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007934

Enrollment

Registered

2022-11-24

Start date

2022-09-30

Completion date

Unknown

Last updated

2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The purpose of this study was to evaluate the therapeutic effect of hyperbaric oxygen therapy by measuring transcutaneous oxygen tension before and after hyperbaric oxygen therapy in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age from 18 years to 80 years. 2. Type 1, Type 2 diabetes mellitus patients diagnosed of Wagner grade 2, 3, 4 diabetic foot ulcer more than 3 months before screening. 3. Have previously gone through treatment by Endocrinology or Plastic surgery or Orthopedic surgery department.

Exclusion criteria

Exclusion criteria: 1. Patient undergoing ICU care due to general condition 2. Patients' remaining lifespan to be less than 12 months 3. Patiens contraindicated for Hyperbaric oxygen therapy due to penumothorax, clasutrophobia. 4. Patient gone through amputation or patients who don't have enough normal skin to measure TcPO2. 5. Planning to be pregnant, or currently pregnant. 6. Patient participating, or planning to participate in other interventional research within 4 weeks 7. Subjects who are deemed difficult to conduct clinical trials in the judgment of other principal investigators

Design outcomes

Primary

Measure	Time frame
Transcutaneous oxygen tension	—

Secondary

Measure	Time frame
Wagner grade classification of Diabteic foot	—

Countries

Korea, Republic of

Contacts

Public ContactHyunsuk Suh

Asan Medical Center

slimtj@hanmail.net+82-2-3010-3608

Outcome results